Skyler Jackson
Physician Assistant · Chicago, ILNPI 1831825017
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 676 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 39 manufacturers reported payments, led by Viiv Healthcare Company at 26.5% of the total. Among physician assistant clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 676 payments — averaging $23.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$4K
- Gilead$2K
- EMD Serono, Inc.$2K
- AbbVie$1K
- Novo Nordisk$1K
- AstraZeneca$905
- plus $5K from 33 others
What the payments were for
- Food & beverage$16,220100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,220 in reported general payments places this provider in the 95th percentile of 3,912 physician assistant providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Egrifta SvTesamorelin Acetate | 17 | $162,634 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 36 | $138,457 |
| RukobiaFostemsavir Tromethamine | 11 | $115,363 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 11 | $73,348 |
| DescovyEmtricitabine/Tenofov Alafenam | 24 | $71,488 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 14 | $64,566 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 11 | $49,202 |
| JulucaDolutegravir/Rilpivirine | 12 | $40,756 |
| TivicayDolutegravir Sodium | 11 | $39,398 |
| DovatoDolutegravir Sodium/Lamivudine | 13 | $38,784 |
| OzempicSemaglutide | 39 | $35,719 |
| MounjaroTirzepatide | 24 | $24,388 |
| EliquisApixaban | 29 | $19,859 |
| Testosterone | 42 | $6,065 |
| Testosterone Cypionate | 32 | $2,043 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Viiv Healthcare CompanyTriumeq, Rukobia, Juluca, Tivicay, Dovato | $4,302 | $372,75983 claims |
| Theratechnologies Inc.Egrifta Sv | $681 | $162,63417 claims |
| GileadDescovy, Genvoya | $1,601 | $120,69035 claims |
| Novo NordiskOzempic | $1,150 | $35,71939 claims |
| Lilly USA, LLCMounjaro | $458 | $24,38824 claims |
| PfizerEliquis | $434 | $19,85929 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,912 physician assistant providers in Illinois.
Other physician assistant in Chicago
- Andrew MastroChicago$419K
- Renata BlockChicago$103K
- Margaret RomanoChicago$82K
- Christina StarksChicago$77K
- Kelly OconnorChicago$36K
- Christa CooperChicago$36K
- Audrey FenwickChicago$29K
- Amy LadewskiChicago$29K
- Lindsey KalhagenChicago$21K
- Jessica KarlChicago$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.